Dig into Annual Meeting On Demand with these favorite courses
June 9, 2026
The top science and education from the world’s largest event for neurology—the Â鶹´«Ã½Ó³» Annual Meeting—is just a click away with .
Check out some of this year’s most-watched sessions:
This practical, interactive, and comprehensive overview is for everyone from trainees to seasoned clinicians and allied health professionals. Designed to be a fun "brain dump" of information from subspecialty experts, this course will offer a one-stop, efficient update on all included areas of neurology practice. Participants should gain knowledge that can be applied directly to their practice, including inpatient & outpatient management strategies. (7.5 CME)
Participants should become familiar with the differential diagnosis of neurological manifestations of rheumatological, systemic inflammatory, and other autoimmune diseases; be able to identify common phenotypes associated with neurological organ system involvement of rheumatological syndromes; learn ways of distinguishing neuro-rheumatological diagnoses from other neuroinflammatory disorders; and develop practical approaches to treatment, care coordination, and health maintenance for neuro-rheumatological conditions. (2 CME)
Participants should be able to identify the current state of blood-based biomarkers for the diagnosis of Alzheimer's disease and appraise the potential utility of these biomarkers for monitoring treatment with amyloid-beta immunotherapies; review the data on the real-world application of amyloid-beta immunotherapies including specific cases that illustrate safety, monitoring, and clinical outcomes; and examine the reasons for, evaluation of, and treatment approach to sleep disorders in Alzheimer's and related dementias—a source of significant burden to patients and caregivers. (2 CME)
Researchers present nine abstracts covering a wide variety of scientifically important new studies and trials. To be included in a Late-breaking Science session, presentations must include key aspects of research conducted after the meeting’s main October 2025 abstract submission deadline. (No CME)
Ten researchers present new studies and analyses on various aspects of epilepsy. (No CME)
Participants should improve knowledge and recognition of stiff person syndrome and other autoimmune movement disorders to help clinicians improve diagnostic accuracy and timeliness; review current approaches in the diagnostic work up and evidence-based treatments in stiff person syndrome and other autoimmune movement disorders; increase clinician confidence in advanced and emerging therapies by reviewing indications, safety considerations, and novel treatments and clinical trials, including CAR T-cell–based approaches for severe or treatment-resistant disease. (2 CME)
Participants should gain a comprehensive understanding of progressive MS, including basic concepts, metrics, and biomarkers and their clinical application; explore emerging strategies for remyelination and neuroprotection; discuss current and evolving approaches to DMT management; and evaluate strategies to promote brain health and optimize functional status in this patient cohort. (2 CME)
Participants should be able to discuss ICU care of ischemic stroke and reperfusion issues, address medical management of subarachnoid patients, and identify ICU needs of patients with intraparenchymal hemorrhagic lesions. Topic reviews and case-based scenarios will be used to present clinical scenarios and patient management. (2 CME)
Participants should be able to describe neuroanatomical structures and pathways relevant to clinical localization, including those of the central nervous system (corticospinal tracts, dorsal columns, spinothalamic tracts, visual pathways, cortical regions and vascular territories, brainstem/cranial nerves, cerebellum) and peripheral nervous system (plexuses, nerve roots, peripheral nerves), and be able to reason through clinical cases to determine the most likely localization. (4.5 CME)
Participants should be able to identify key social, environmental, financial, and political determinants of brain health, building on concepts from prior years sessions; describe how early-life, community, and environmental exposures such as toxins, pollution, lead, and food insecurity influence neurological development and disease risk; explain how financial and political forces (insurance coverage, reimbursement, Medicaid policy, legislation, and Supreme Court decisions) shape access to neurological care; analyze clinical scenarios to distinguish how financial barriers and political determinants contribute to inequities in diagnosis, treatment, and outcomes; and propose practical clinical and policy strategies that neurologists can use to promote more equitable brain health. (2 CME)
What will be your favorites?
Thousands of your neurology colleagues from around the globe are already exploring Annual Meeting On Demand’s 500+ hours of content and enjoying access through March 1, 2027, with the ability to earn and claim up to 375 hours of CME. Annual Meeting On Demand even offers transcripts in French, German, Italian, Portuguese, and Spanish for plenary sessions and select popular courses, making the Annual Meeting’s sessions more accessible than ever.
So, what are you waiting for? Dig into today!